Back

Beyond assumptions: NT-proBNP rise and diuretic strategies in HFrEF therapy up-titration

12 May 2024 (15:00 - 15:45)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - treatment 13 Pharmacotherapy HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Mr Diogo Ferreira

Santa Maria Hospital - CHULN, Lisbon (Portugal)

4 More presentations in this session

Presentation thumbnail
Effects of sodium-glucose cotransporter 2 inhibitors on pulmonary hemodynamics in chronic heart failure patients and a pulmonary artery pressure sensor: does left ventricular ejection fraction matter?
Doctor E. Santiago-Vacas (Badalona, ES)
Abstract Slides Video
Presentation thumbnail
Impact of beta-blocker therapy in patients with preserved left ventricular ejection fraction after ST-segment elevation myocardial infarction
Doctor C. Carvalho (Viana do Castelo, PT)
Abstract Slides Video
Presentation thumbnail
Impact of the guideline-directed medical therapy on the eligibility of patients for mitral valve transcatheter edge-to-edge repair in HFrEF
Doctor B. Muk (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Initial 6-hour injectable diuretic therapy on 24-month outcomes in acute heart failure patients
Doctor A. Singh (Manipal, IN)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic heart failure - treatment 13

The Event

Event poster

Heart Failure 2024

12 May 2024 15:00 CET
You may be interested in
thumbnail
Congress Presentation
The prognostic role of regular NT-proBNP measurement after a rapid-up titration programme of guideline-directed medical therapy in heart failure: essential or superfluous?
thumbnail
Congress Presentation
Heart failure
thumbnail
Congress Presentation
Prognosis and NT-proBNP decrease in heart failure patients from admission to follow up

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources